Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Finasteride safely lowers DHT levels without affecting testosterone.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Androgens reduce BMP2, which weakens the ability of certain cells to help hair stem cells become different types of cells.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

The mouse models are effective for testing new hair loss treatments.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Human scalp hair follicles have PGE2 and its receptors, which might affect hair growth.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

MC4R gene variants not linked to female hair loss.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.